Phase II study of a combination of TS-1 and TXL for advanced/recurrent gastric cancer patients with peritoneal metastasis.
Phase of Trial: Phase II
Latest Information Update: 05 Dec 2009
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel
- Indications Gastric cancer
- Focus Therapeutic Use
- 05 Dec 2009 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
- 03 Jul 2007 New trial record.